1. Association between electrocardiographic and echocardiographic markers of stage B heart failure and cardiovascular outcome. (12th April 2017) Authors: Yang, Hong; Marwick, Thomas H.; Wang, Ying; Nolan, Mark; Negishi, Kazuaki; Khan, Faisal; Okin, Peter M. Journal: ESC heart failure Issue: Volume 4:Number 4(2017) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Build It, But Will They Come? A Geoscience Cyberinfrastructure Baseline Analysis. (11th July 2016) Authors: Cutcher-Gershenfeld, Joel; Baker, Karen S.; Berente, Nicholas; Carter, Dorothy R.; DeChurch, Leslie A.; Flint, Courtney C.; Gershenfeld, Gabriel; Haberman, Michael; King, John Leslie; Kirkpatrick, Christine; Knight, Eric; Lawrence, Barbara; Lewis, Spenser; Lenhardt, W. Christopher; Lopez, Pablo; ... Journal: Data science journal Issue: Volume 15(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Echocardiographic screening for non‐ischaemic stage B heart failure in the community. (November 2016) Authors: Yang, Hong; Negishi, Kazuaki; Wang, Ying; Nolan, Mark; Saito, Makoto; Marwick, Thomas H. Journal: European journal of heart failure Issue: Volume 18:Number 11(2016) Page Start: 1331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Editorial change at Psychiatry, Psychology and Law: we stand on the shoulders of a giant. Issue 4 (3rd July 2020) Authors: Nolan, Mark Journal: Psychiatry, psychology, and law Issue: Volume 27:Issue 4(2020) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EMA approved new drug: cabazitaxel (Jevtana): Promising advances in prostate cancer treatment. Issue 4 (30th August 2012) Authors: Nolan, Mark Journal: European journal of hospital pharmacy Issue: Volume 19:Issue 4(2012) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EMA approved new drugs: ipilimumab (Yervoy) for the treatment of malignant melanoma. Issue 6 (23rd November 2012) Authors: Nolan, Mark Journal: European journal of hospital pharmacy Issue: Volume 19:Issue 6(2012) Page Start: 550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EMA approved new drugs: Photodynamic therapy for actinic keratosis. Issue 1 (10th January 2013) Authors: Nolan, Mark Journal: European journal of hospital pharmacy Issue: Volume 20:Issue 1(2013) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EMA approved new drugs: telaprevir and boceprevir: Direct acting antivirals rewrite guidelines for the treatment of hepatitis C. Issue 3 (23rd June 2012) Authors: Nolan, Mark Journal: European journal of hospital pharmacy Issue: Volume 19:Issue 3(2012) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EMEA approved new drugs: Vinflunine. Issue 1 (29th February 2012) Authors: Nolan, Mark Journal: European journal of hospital pharmacy Issue: Volume 19:Issue 1(2012) Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Framing the Australian extreme right: proposing a threefold typology with consideration of legislation and listing regulations. Issue 3 (3rd July 2023) Authors: Campion, Kristy; Nolan, Mark; O'Brien, Nick Journal: Journal of policing, intelligence and counter terrorism Issue: Volume 18:Issue 3(2023) Page Start: 282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗